Parthenolide-minus-Parthenolide-DataSheet-生命科学试剂-MedChemExpress_第1页
Parthenolide-minus-Parthenolide-DataSheet-生命科学试剂-MedChemExpress_第2页
Parthenolide-minus-Parthenolide-DataSheet-生命科学试剂-MedChemExpress_第3页
Parthenolide-minus-Parthenolide-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEParthenolideCat. No.: HY-N0141CAS No.: 20554-84-1Synonyms: (-)-Parthenolide分式: CHO分量: 248.32作靶点: NF-B; Autophagy; Mitophagy作通路: NF-B; Autophagy储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO

2、: 100 mg/mL (402.71 mM)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (8.38 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)1/3 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.08 mg/mL (8.38 mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubilit

3、y: 2.08 mg/mL (8.38 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Parthenolide在药草短匹菊中发现的倍半萜内酯。 Parthenolide通过抑制 NF-B 活化表现出抗炎活性;它还可抑制 HDAC1 蛋不影响其他I/II类HDAC。IC50 & Target NF-B Autophagy Mitophagy体外研究 Parthenolide (PTL) has a dose-dependent growth inhibition effect on NSCLC cells Calu-1, H1792, A549,H1299,

4、 H157, and H460. Parthenolide can induce cleavage of apoptotic proteins such as CASP8, CASP9,CASP3 and PARP1 both in concentration- and time-dependent manner in tested lung cancer cells, indicatingthat apoptosis is trigged after Parthenolide exposure. In addition to induction of apoptosis, Parthenol

5、ide alsoinduces G0/G1 cell cycle arrest in a concentration-dependent manner in A549 cells and G2/M cell cyclearrest in H1792 cells 2.体内研究 Only Parthenolide, the HDAC inhibitor with anti-inflammatory features, displayed a potent anti-apoptoticeffect in Phb1 KO hepatocytes. Indeed, TSA and Parthenolid

6、e-treated hepatocytes showed increased levelsof FXR, and reduced levels of CYP7A1, HDAC4, TNF, TRAIL and Bax suggesting a less toxic effect of bileacids as a results of specific HDAC inhibition, resulting in the attenuation of the Phb1 KO hepatocytesapoptotic response. Importantly, Parthenolide exer

7、ts a protective effect from the liver injury after BDL in Phb1KO mice. Indeed, Parthenolide treatment results in a reduction of the mortality rate of this mice after BDLassociated with a lower apoptotic response as revealed by a reduction of necrotic areas, Tunel-staining, aswell as decreased ALT (8

8、431957 vs.4225210 U/L) and AST (4805300 vs.2242438 U/L) activitiescompared to control Phb1 KO mice 3.PROTOCOLCell Assay 2 Human lung cancer cell lines are seeded in 96-well plates and treated on the second day with the givenconcentration of Parthenolide (0, 5, 10, 20 M) for another 48 hours and then

9、 subjected to SRB or MTTassay. For SRB assay, live cell number is estimated as described earlier. After treatment, the medium isdiscarded firstly. In order to fix the adherent cells, 100 L of cold trichloroacetic acid (10% (w/v) are addingto each well and incubating at 4C for at least 1 hour. The pl

10、ates are then washed five times with deionizedwater and dried in the air. Each well are then added with 50 L of SRB solution (0.4% w/v in 1% acetic acid)and incubated for 5 min at room temperature. The plates are washed five times with 1% acetic acid toremove unbound SRB and then air dried. The resi

11、dual bound SRB is solubilized with 100 L of 10 mM Trisbase buffer (pH 10.5), and then read using a microtiter plate reader at 495 nm. The MTT assay is executed.20 L MTT (5 mg/mL) are added to each sample and incubate at 37C for 4 h, then 100 L solubilizationsolution are added. Cell viability is dete

12、rmined at 595 nm 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEAnimal Mice 3Administration 3 Phb1 KO mice are used. Males from 8-12 weeks of age are treated. Parthenolide is intraperitoneally injected

13、at a dose of 3 mg/kg 24 h and 1h before bile duct ligation (BDL) or twice a week during two weeks. Liverspecimens are snap-frozen for subsequent analysis 3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 Proc Natl Acad Sci U S A. 2019 Feb 19

14、;116(8):2961-2966. Cancer Lett. 2018 Aug 1;428:77-89. J Mol Med (Berl). 2019 Jun 14.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Nakshatri H, et al. NF-B-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT. Cell Death Dis.2015 Jan 22;6:e1608.2. Zhao X, et al. Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells. J Exp Clin CancerRes. 2014 Jan 6;33:3.3. Barbier-Torres L, et al. Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1. Hepatology.

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论